Biotech Blueprint

Biotech Blueprint

Home
This Week in Biotech
Startup Spotlight
Deep Dives
Website
Archive
Leaderboard
About

Deep Dives

Organoids, AI, and the FDA’s Move Away from Animal Models
Inside the FDA’s push to replace lab animals with human tissues & algorithms — with scientist Dr. Patrick Creisher.
 • 
Katerina Roznik
4
New contenders, old headwinds: global biotech looks to China
Western biotech faces a tougher funding climate, while Chinese firms move faster and aim higher, reshaping the industry’s global balance.
 • 
Katerina Roznik
 and 
Erin Mihealsick
3
What a global trade fight means for biotech
Biotech is already feeling the pinch from tariffs. What happens if pharmaceuticals are next?
 • 
Katerina Roznik
2
Psychedelic medicine as the new frontier in mental health care?
How changing political landscape and confirmation of RFK Jr. as HHS secretary may be paving the way for psychedelic therapies in mental health.
 • 
Katerina Roznik
Key drugs to keep an eye on in 2025
A deep dive into seven drugs with the potential for FDA approval in 2025, spanning from pain management to rare diseases.
 • 
Katerina Roznik
2
The future of mRNA: companies and trials to watch in 2025
Exploring the next wave of mRNA innovation in cancer, infectious diseases, and beyond. What will 2025 bring?
 • 
Katerina Roznik
The expanding landscape of GLP-1 drugs: What's next in the race for new treatments?
A deep dive into the latest GLP-1 clinical trials and the companies behind them
 • 
Katerina Roznik
1
Fauci's West Nile Virus infection highlights the need for vaccine and drug development
Limited progress in West Nile Virus research reveals gaps in our public health arsenal
 • 
Katerina Roznik
1
Global alarm as new monkeypox (mpox) strain fuels surge across Africa and beyond
Few days ago, the WHO declared international emergency amid rapid spread of the new mpox virus strain.
 • 
Katerina Roznik
FDA blocks MDMA therapy for PTSD—What’s next for mental health breakthroughs?
Inside the FDA’s recent decision and what it means for the future of psychedelic medicine
 • 
Katerina Roznik
1
Longevity revolution: How close are we to living past 120
The anti-aging research boom, its challenges, and the promising therapies that could redefine human healthspan.
 • 
Katerina Roznik
GLP-1 Drugs: The Science and the Scarcity
How breakthroughs in GLP-1 science are creating new challenges.
 • 
Katerina Roznik
© 2025 Katerina
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture